The roadmap to geographic atrophy treatment: A journey of trials and promise

Omer Trivizki; Anat Loewenstein; Dinah Zur

doi:10.1111/aos.15801

The roadmap to geographic atrophy treatment: A journey of trials and promise

Acta Ophthalmol. 2023 Dec;101(8):891-895. doi: 10.1111/aos.15801.

Authors

Omer Trivizki^{1

2}, Anat Loewenstein², Dinah Zur²

Affiliations

¹ Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, Miami, Florida, USA.
² Ophthalmology Division, Tel Aviv Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

PMID: 37933605
DOI: 10.1111/aos.15801

Abstract

This review covers advancements in geographic atrophy (GA) research. It discusses genetic contributions to AMD, explores treatment strategies, including complement inhibition, and highlights recent FDA approvals, safety concerns and promising future directions.

Publication types

Review

MeSH terms

Geographic Atrophy*
Humans
Macular Degeneration* / genetics